Event Brief
Hengrui signs up to $15.2 billion deal with BMS
Filed: May 12, 2026 at 7:05 AM ET
Summary: Jiangsu Hengrui Pharmaceutical signed a global collaboration and licensing agreement with Bristol Myers Squibb worth up to $15.2 billion.
WHO: Jiangsu Hengrui Pharmaceutical
WHAT: Signed a global collaboration and licensing agreement with Bristol Myers Squibb worth up to US$15.2 billion
WHEN: May 12, 2026 at 6:00 AM ET
WHERE: Jiangsu, China
WHY: To establish a global collaboration and licensing agreement with BMS.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →